AKAkoï Koïvogui

Akoï Koïvogui

*This is an algorithmically generated author record based on publicly available information.

Akoï Koïvogui has a total of 108 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluation of the impact of a third mammographic reading in the French population-based breast cancer screening program

    by Akoï Koïvogui, Samira Saifi, Malala Razafija, Patrick Mensah, Agnès Bernoux, Pascal Cherel, Nicolas Sellier

  • Combining artificial intelligence analysis with expert mammogram reading: Determining the optimal AI positivity cut-off point for the French population-based breast cancer screening program

    by Akoï Koïvogui, Gaëlle Abihsera, Samira Saifi, Michel Deghaye, Dominique Lamarque, Pascal Cherel, Guillaume Herpe, Nicolas Sellier

  • Open Access

    Evaluation of the impact of a third mammographic reading in the French organized breast cancer screening program

    by Akoi Koivogui, Samira Saifi, Malala Razafija, Helene Delattre, Patrick Mensah, Agnes Bernoux, Pascal Cherel, Nicolas Sellier

    Background Population-based breast cancer screening program (PBCSP) in France relies on a double reading of mammograms. To limit overdiagnosis and false-positives, a third reading (Read-3) was implemented. This study evaluates its impact in terms of the incidence of interval cancers (Interval-Cancer). Methods The retrospective cohort study includes 1,328,597 mammograms (MT0) classified as negative in Reading-1 and reviewed in Reading-2. These MT0 were performed between 2001 and 2022 on 426,603 women aged 50-74 years, residing in Seine-Saint-Denis and Val-d’Oise, France. Two groups were compared: i)- Mammo-Index classified as negative in Read-2 (Control-Group, 1,312,341 MT0); ii)- Mammograms-Index initially positive in Read-2 but reclassified as negative in Read-3 (Experimental-Group, 16,256 MT0). Two hierarchical models explored the determinants of positivity in Read-2 and Read-3. The incidence of cancers, particularly Interval-Cancer (≤23 months after Mammograms-Index), were compared using an adjusted Cox proportional Hazard-ratio model. Results Confirmation of positivity by Read-3 was more likely when the radiological abnormality (Architectural-distortion, Focal-asymmetry, Microcalcifications, Round-mass, Spiculated-mass) was seen in Read-3, regardless of the assessment made in Read-2. The risk of Interval-Cancer was higher in the Experimental-Group (Hazard-ratio=2.1 [1.4–3.2], p=0.009). However, no increased risk was observed beyond 24 months (Hazard-ratio=0.9 [0.7–1.2], p =0.52). Read-3 avoided more than 6,000 ultrasounds, 700 biopsies, and nearly 7,600 additional mammograms. Conclusion While it reduces the overuse of exams, Read-3 increases the Interval-Cancer risk. These results underline the interest of a national reflection on the place of a targeted Read-3 with a security reference framework, or even its replacement by AI-based decision-making tools.

  • Mieux atteindre, cibler et caractériser les patients relevant du dépistage organisé du CCR en France : place des bases médico-administratives et des réseaux sociaux

    by Akoi Koivogui

    Toutes les conditions justifiant la mise en place d'une politique de dépistage sont remplies par le cancer colorectal (CCR) : il est fréquent (43 000 nouveaux cas en France chaque année), grave (on ne guérit actuellement qu'un cancer sur deux) et s'il est diagnostiqué au début, il est habituellement guéri. Ce cancer peut être prévenu par la détection et l'exérèse des adénomes qui le précèdent le plus souvent. Enfin, il existe une stratégie de dépistage reposant sur la recherche d'un saignement occulte dans les selles par un test réalisé tous les 2 ans. En France, le taux de participation aux campagnes de dépistage atteint rarement 50% dans la plupart des départements français. Nous cherchions à vérifier deux hypothèses : i)l'exploitation de plusieurs sources de données, notamment les bases de données médico-administratives et les registres de cancers, permettrait de mieux cibler et caractériser les personnes éligibles aux campagnes de dépistage en France, ce qui améliorerait considérablement le taux d'exclusion médicale ; ii) la promotion du dépistage à travers les réseaux sociaux permettrait d'atteindre les personnes non participant aux campagnes de dépistage, ce qui améliorerait considérable l'effectif de participants à une campagne de dépistage. Dans cette thèse, nous nous sommes fixés pour objectif de développer des approches pour mieux cibler, caractériser et atteindre les patients relevant du dépistage en France, en s'intéressant en particulier à l'apport de la réutilisation de données médico-administratives et l'usage de réseaux sociaux. Notre approche méthodologique a été de comparer d'abord les définitions internationales des populations cible du dépistage et la place des bases de données médico-administratives dans les méthodologies de ciblage des populations éligibles aux campagnes de dépistage à travers le monde. Une synthèse des différents profils de personnes atteintes d'une situations morbides pouvant justifier d'une exclusion médicale a été faite. La définition de la personne a été faite à l'aide de critères d'exclusion consensuels dans les programmes internationaux dans le de la transcrire en requête pour pouvoir exclure les personnes du dépistage à partir des données du Système national des données de santé (SNDS). A l'aide d'un module de géolocalisation et de sensibilisation sur le réseau social Facebook, nous avons analyser l'apport des réseaux sociaux comme sources supplémentaires de motivation des personnes à participer aux campagnes de DOCCR.Cette thèse met en évidence des stratégies et moyens d'exploitation de plusieurs sources de données pour une optimisation des campagnes de DOCCR en France. La thèse montre aussi que ces sources de données n'étaient pas encore exploitées en France dans le cadre du dépistage du cancer colorectal. Pour consolider la définition de la population éligible au DOCCR, l'intérêt du développement d'une méthode d'identification à partir des données de consommation de soins du SNDS a été largement argumenté dans cette thèse. Nous avons argumenté l'accès aux données du SNDS et le projet suit son cours en guise de perspective à la thèse. Nous envisageons aussi, la mise en place et l'évaluation à grande échelle d'une stratégie complémentaire d'optimisation des campagnes de DOCCR à travers les réseaux sociaux notamment Facebook car l'expérimentation n'avait ciblé que six communes d'un seul département.

  • Open Access

    Role of medico-administrative database in the selection of the target population in colorectal cancer screening program

    by Akoï Koïvogui, Robert Benamouzig, Christian Balamou, Gemma Binefa, Sarah Hoeck, Dominika Novak-Mlakar, Catherine Duclos

    Background: Colorectal cancer (CRC) screening in average-risk populations requires filtering a target population based on medical information in population-based CRC screening programs (CRCSP). This study describes the level of consensus in medical exclusion practice and the role of the medico-administrative databases (MADB) in accurately targeting the eligible individuals for CRCSP screening campaigns. Design: The descriptive study combined a cross-sectional survey and a non-systematic literature review. Methods: A cross-sectional survey was conducted among CRCSPs worldwide. Information was collected on the use of MADB for identifying consensus-based exclusion criteria (applied by >50% of CRCSPs). When a MADB was used, the study assessed whether the definition (code lists, medical terminologies) of the exclusion criteria was available. These definitions were compared between programs to evaluate the degree of consensus. Results: In all, 20 out of the 31 CRCSPs (Australia, England, Manitoba, Ontario, Washington State, 26 European countries) participating in the survey implemented medical exclusions. Five consensus-based exclusion criteria were identified (personal history of CRC, inflammatory bowel disease, adenoma, recent colonoscopy, genetic risk). However, these criteria were not uniformly defined in MADBs (i.e., CRC phenotype includes ICD-10 codes C18–C21 in Catalonia, while the C21 code was excluded elsewhere). Furthermore, although the MADBs exist and contain relevant information, they remain inaccessible to screening management structures in some countries (e.g., in France). Conclusion: The number of consensus-based criteria was limited, and they were the least nuanced, likely because they are easier to collect using the current CRCSPs management resources. These consensual criteria can be queried in most MADBs. However, the use of MADBs was not standardized across programs for various reasons (absence of a database, unavailability of information in the database when it exists, inaccessibility of the database when it exists), limiting comparability between them. Standardizing the five consensus criteria across all programs would only be effective if the disparity caused by systemic failures in the organization of each program was controlled.

  • Evaluation of the severity of screened colorectal cancer in the context of the health crisis linked to COVID19 in Ile-de-France region

    by Akoï Koïvogui, Gaëlle Abihsera, Tu Le Trong, Hamou Ait-Hadad, Agnès Bernoux, Hélène Delattre, Catherine Vincelet, Rachel Caroll, Jerôme Nicolet


  • Open Access

    Supply and quality of colonoscopy according to the characteristics of gastroenterologists in the French population-based colorectal-cancer screening program

    by Akoï Koïvogui, Catherine Vincelet, Gaëlle Abihsera, Hamou Ait-Hadad, Hélène Delattre, Tu Le Trung, Agnès Bernoux, Rachel Carroll, Jérôme Nicolet

    Since its complete roll-out in 2009, the French colorectal cancer screening program (CRCSP) experienced 3 major constraints [use of a less efficient Guaiac-test (gFOBT), stopping the supply of Fecal-Immunochemical-Test kits (FIT), and suspension of the program due to the coronavirus disease 2019 (COVID-19)] affecting its effectiveness. To describe the impact of the constraints in terms of changes in the quality of screening-colonoscopy (Quali-Colo). This retrospective cohort study included screening-colonoscopies performed by gastroenterologists between Jan-2010 and Dec-2020 in people aged 50-74 living in Ile-de-France (France). The changes in Quali-colo (Proportion of colonoscopies performed beyond 7 mo (Colo_7 mo), Frequency of serious adverse events (SAE) and Colonoscopy detection rate) were described in a cohort of Gastroenterologists who performed at least one colonoscopy over each of the four periods defined according to the chronology of the constraints [gFOBT: Normal progress of the CRCSP using gFOBT (2010-2014); FIT: Normal progress of the CRCSP using FIT (2015-2018); STOP-FIT: Year (2019) during which the CRCSP experienced the cessation of the supply of test kits; COVID: Program suspension due to the COVID-19 health crisis (2020)]. The link between each dependent variable (Colo_7 mo; SAE occurrence, neoplasm detection rate) and the predictive factors was analyzed in a two-level multivariate hierarchical model. The 533 gastroenterologists (cohort) achieved 21509 screening colonoscopies over gFOBT period, 38352 over FIT, 7342 over STOP-FIT and 7995 over COVID period. The frequency of SAE did not change between periods (gFOBT: 0.3%; FIT: 0.3%; STOP-FIT: 0.3%; and COVID: 0.2%; P = 0.10). The risk of Colo_7 mo doubled between FIT [adjusted odds ratio (aOR): 1.2 (1.1; 1.2)] and STOP-FIT [aOR: 2.4 (2.1; 2.6)]; then, decreased by 40% between STOP-FIT and COVID [aOR: 2.0 (1.8; 2.2)]. Regardless of the period, this Colo_7 mo’s risk was twice as high for screening colonoscopy performed in a public hospital [aOR: 2.1 (1.3; 3.6)] compared to screening-colonoscopy performed in a private clinic. The neoplasm detection, which increased by 60% between gFOBT and FIT [aOR: 1.6 (1.5; 1.7)], decreased by 40% between FIT and COVID [aOR: 1.1 (1.0; 1.3)]. The constraints likely affected the time-to-colonoscopy as well as the colonoscopy detection rate without impacting the SAE’s occurrence, highlighting the need for a respectable reference time-to-colonoscopy in CRCSP.


  • Open Access

    Prevalence of Intestinal Parasitosis in Guinea: Systematic Review of the Literature and Meta-Analysis

    by Timothé Guilavogui, Stéphane Verdun, Akoï Koïvogui, Eric Viscogliosi, Gabriela Certad

    Background: Intestinal parasitosis constitute a major public health issue, particularly in sub-tropical and tropical areas. Even though they are classified as neglected tropical diseases, no national study has been carried out recently in Guinea to estimate the prevalence of intestinal parasitosis. Objective: A systematic review and meta-analysis aimed to determine the overall prevalence of intestinal parasitosis in Guinea. Method: The PRISMA method was used to perform a systematic review and meta-analysis. The studies carried out in order to study intestinal parasitosis in Guinea and published between 2010 and 2020 were searched in online public databases. The prevalence of parasitosis was calculated by a random-effects meta-analysis. Subgroup comparisons were performed using Q-tests. Statistical analyses were performed with the R software. This review was registered with PROSPERO under the identification number CRD42022349743. Results: 69 studies were selected out of 1230 studies identified in online public databases. The meta-analysis involved 44,186 people with an overall prevalence of intestinal parasitic infections of 52%. Conclusions: This is the first study in Guinea to assess the prevalence of intestinal parasitic infections in different regions of the country. It was found that intestinal parasitosis are a real health problem in Guinea, hence, the need to put in place national strategies for regular control.